The Global Blood Cell Separator Market size is projected to grow at a CAGR of close to 5.4% during the forecast period. The single-component for the blood transfusion segment accounted for nearly 60% of the global market share in 2016 and will continue its dominance over other segments by retaining more than 55% of the share throughout 2021-2028.
A blood cell separator is a device used in the healthcare industry for removing components of whole blood and preparing them to be transfused. It is an apparatus used in the processing of whole blood to obtain blood components such as red cells, platelets, and plasma. Blood cell separators are typically utilized in hematology laboratories or cellular therapy centers where they can be connected to a donor's vein through tubing that carries the withdrawn fluid into the machine for processing.
On the basis of Type, the global blood cell separator market is segmented into Single Components for Blood Transfusion and Therapeutic blood components isolated.
Single Components for Blood Transfusion type of blood cell separator are used to treat patients with conditions that require an increased red blood cells count. It is used to separate the single component from whole human blood by centrifugation. The technology has gained popularity in recent years because it provides an alternative to conventional multi-component systems, which are laborious and require extensive manual processing.
Therapeutic blood components isolated type of a machine is used to separate components from a donor's collected whole blood. This kind of equipment separates out red cells, plasma, and platelets in the final containers for storage or transfusion purposes. The major benefit of this type is that it allows the collection of platelets, leukocytes, and erythrocytes in a single system.
Therapeutic blood components isolated type of blood cell separator is the process where therapeutic apheresis products are prepared. The purified plasma and desired cellular elements, also known as "therapeutic cells" may be collected from donated whole blood or by means of Plasmapheresis (also called plasma exchange). These products can then be used for transfusion to specific patients with a variety of conditions that require infusion with these therapeutics ides including acquired immune deficiency syndrome.
On the basis of Application, the global blood cell separator market is segmented into Hospital, Blood Collection stations & others.
In hospitals, the blood cell separator is used to separate different parts of blood. The separated components include red cells and plasma as well as platelets. In addition, the machine can remove white cells from a sample of the blood too. The blood cell separator is used in hospitals for the treatment of various types of anemia. The device has several advantages over older technologies like manual centrifugation.
There are many applications of the blood cell separator in Blood Collection stations, including Blood component preparation for a blood transfusion. Collection of stem cells from peripheral or cord blood, which can then be stored to allow future treatment with the patient's own immune system. This approach is called autologous hematopoietic stem cell transplantation (AHSCT). The depletion of T lymphocytes from the blood for the treatment of Graft versus Host Disease (GVHD). This can be achieved by negative selection. The depletion of T lymphocytes and CD34+ cells from the peripheral blood for prevention of GVHD. This can be achieved by positive selection.
On the basis of Region, the global blood cell separator market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to dominate the global market throughout the forecast period on account of the high prevalence of blood disorders in this region which is also driven by an increasing number of transfusion cases for various applications like cancer treatment mainly due to its availability at low costs.
Europe is a matured market is estimated to have significant growth in the near future due to an increased demand for blood transfusion owing to the high prevalence of thalassemia across Europe, coupled with rising in the number of cases involving leukemia & immune system disorder which will drive the regional market over next few years. The market in the Latin American region is expected to grow with a high CAGR between 2021-2028 owing to an increase in the prevalence of blood diseases, increasing the number of transfusion procedures, and a rise in adoption rates for blood collection & production across the region.
The market in the Asia Pacific is anticipated to witness significant growth on account of the rising prevalence of blood disorders and growing awareness about safety & efficacy. The major players profiled are Fresenius SE, Terumo Corporation, Sysmex Corporation Limited, Thermo Fisher Scientific Inc., JMS Co., Ltd., Fenwal Holdings Inc. (Terumo BCT), Sechrist Medical Products LLC, Biomérieux SA, and Sekisui Diagnostics America Incorporated among others. China is identified as one of the most promising markets with a high growth rate owing to an increase in healthcare expenditure along with a growing population base that requires quality medical products such as cell separators at reduced costs globally.
The key factor that drives the growth in the market includes increasing adoption rate for blood transfusion and therapeutic components, growing awareness about safety & effectiveness of automated systems among patients and healthcare providers as well as the availability of advanced processing technologies such as centrifuges, compatible disposable products with high output, easy operating machines, etc. The growing global geriatric population, increasing medical tourism, and rise in demand for blood transfusion will drive the growth of this market.
Up Market Research published a new report titled “Blood Cell Separator Market research report which is segmented by Types (Single Component for Blood Transfusion, Therapeutic Blood Components Isolated), By Applications (Hospital, Blood Collection Station, Others), By Players/Companies Fresenius, Haemonetics Corporation(HAE), Terumo, Sichuan Medical And Health Rroducts Cosmetics Quality Management Assoclation”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Blood Cell Separator Market Research Report |
By Type | Single Component for Blood Transfusion, Therapeutic Blood Components Isolated |
By Application | Hospital, Blood Collection Station, Others |
By Companies | Fresenius, Haemonetics Corporation(HAE), Terumo, Sichuan Medical And Health Rroducts Cosmetics Quality Management Assoclation |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 211 |
Number of Tables & Figures | 148 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Single Component for Blood Transfusion, Therapeutic Blood Components Isolated and By Application Hospital, Blood Collection Station, Others.
Some of the companies that are profiled in this report are:
Blood Cell Separator Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Blood Cell Separator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Blood Cell Separator Market Report:
Some other reports from this category!